BackBioPharma Credit PLC Overview

BioPharma Credit PLC Receivables

Latest receivables for BOPCF: $15M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$15.04M
↓ 72.25% YoYΔ $-39.16M vs prior year quarter

Peer trimmed avg / median

Loading

BioPharma Credit PLC Receivables History

Loading

BioPharma Credit PLC vs. peers: Receivables Comparison

Loading

BioPharma Credit PLC Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BioPharma Credit PLC (BOPCF) FAQ

As of the most recent data (June 2026), BOPCF shows a receivables of $15M. That compares with $54M in the prior-year period — down 72.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BOPCF's receivables is now $15M (was $54M) — a 72.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioPharma Credit PLC is outperforming or lagging.

Tracking BOPCF's receivables over time shows whether BioPharma Credit PLC is scaling, shrinking, or reshaping that part of the business. The current reading is $15M That compares with $54M in the prior-year period — down 72.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has BioPharma Credit PLC's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $15M) with ownership activity and broader fundamentals.